SRF and Hepatic fibrosis: All these data suggest that FN1 and SRF are bona fide targets of miR-122, and miR-122 may suppress hepatic fibrosis by simultaneously blocking multiple aspects of fibrogenesis, including collagen production, fibril assembly and ECM contraction.